Literature DB >> 29358019

The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.

B B Brodey1, R R Girgis2, O V Favorov3, J Addington4, D O Perkins5, C E Bearden6, S W Woods7, E F Walker8, B A Cornblatt9, G Brucato10, B Walsh11, K A Elkin12, I S Brodey13.   

Abstract

Machine learning techniques were used to identify highly informative early psychosis self-report items and to validate an early psychosis screener (EPS) against the Structured Interview for Psychosis-risk Syndromes (SIPS). The Prodromal Questionnaire-Brief Version (PQ-B) and 148 additional items were administered to 229 individuals being screened with the SIPS at 7 North American Prodrome Longitudinal Study sites and at Columbia University. Fifty individuals were found to have SIPS scores of 0, 1, or 2, making them clinically low risk (CLR) controls; 144 were classified as clinically high risk (CHR) (SIPS 3-5) and 35 were found to have first episode psychosis (FEP) (SIPS 6). Spectral clustering analysis, performed on 124 of the items, yielded two cohesive item groups, the first mostly related to psychosis and mania, the second mostly related to depression, anxiety, and social and general work/school functioning. Items within each group were sorted according to their usefulness in distinguishing between CLR and CHR individuals using the Minimum Redundancy Maximum Relevance procedure. A receiver operating characteristic area under the curve (AUC) analysis indicated that maximal differentiation of CLR and CHR participants was achieved with a 26-item solution (AUC=0.899±0.001). The EPS-26 outperformed the PQ-B (AUC=0.834±0.001). For screening purposes, the self-report EPS-26 appeared to differentiate individuals who are either CLR or CHR approximately as well as the clinician-administered SIPS. The EPS-26 may prove useful as a self-report screener and may lead to a decrease in the duration of untreated psychosis. A validation of the EPS-26 against actual conversion is underway.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Machine learning; NAPLS; PQ-B; Prodromal; Psychosis; SIPS; Schizophrenia; Screener

Mesh:

Year:  2018        PMID: 29358019      PMCID: PMC6051928          DOI: 10.1016/j.schres.2017.11.030

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Validation of the Prodromal Questionnaire-Brief in a representative sample of adolescents: Internal structure, norms, reliability, and links with psychopathology.

Authors:  Eduardo Fonseca-Pedrero; Felix Inchausti; Alicia Pérez-Albéniz; Javier Ortuño-Sierra
Journal:  Int J Methods Psychiatr Res       Date:  2018-09-10       Impact factor: 4.035

2.  Considerations for the development and implementation of brief screening tools in the identification of early psychosis.

Authors:  Jason Schiffman
Journal:  Schizophr Res       Date:  2018-03-07       Impact factor: 4.939

3.  AI in patient flow: applications of artificial intelligence to improve patient flow in NHS acute mental health inpatient units.

Authors:  Fatema Mustansir Dawoodbhoy; Jack Delaney; Paulina Cecula; Jiakun Yu; Iain Peacock; Joseph Tan; Benita Cox
Journal:  Heliyon       Date:  2021-05-12

Review 4.  Applications of artificial intelligence to improve patient flow on mental health inpatient units - Narrative literature review.

Authors:  Paulina Cecula; Jiakun Yu; Fatema Mustansir Dawoodbhoy; Jack Delaney; Joseph Tan; Iain Peacock; Benita Cox
Journal:  Heliyon       Date:  2021-04-15

5.  Screening of the college students at clinical high risk for psychosis in China: a multicenter epidemiological study.

Authors:  Jiaxin Wu; Xiangyun Long; Fei Liu; Ansi Qi; Qi Chen; Xiaofeng Guan; Qiong Zhang; Yuhong Yao; Jingyu Shi; Shiping Xie; Wei Yan; Maorong Hu; Xin Yuan; Jun Tang; Siliang Wu; Tianhong Zhang; Jijun Wang; Zheng Lu
Journal:  BMC Psychiatry       Date:  2021-05-17       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.